THE LS-ANTIGEN OF VACCINIA : I. INHIBITION OF L- AND S-ANTIBODIES BY SUBSTANCES IN TREATED VACCINE DERMAL FILTRATE.

The Journal of experimental medicine ·Vol. 75 ·No. 2 ·1942-01-31 ·Pages 151-64

Smadel JE, Rivers TM

Abstract

Experimental data are presented which may be interpreted as follows. The heat-labile (L) and heat-stable (S) antigens of vaccinia occur in nature as a complex consisting of a single substance with two serologically active parts, each of which may be degraded independently of the other.

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Smadel J E

Hospital of The Rockefeller Institute for Medical Research.

Rivers T M

References (5)

5 references, click to expand

IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS.
J Exp Med. 1938 Feb 28;67(3):361-7 PMID: 19870726
STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : II. THE SOLUBLE PRECIPITABLE SUBSTANCES OF DERMAL VACCINE.
J Exp Med. 1936 Oct 31;64(5):819-30 PMID: 19870571
SOME CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA.
J Exp Med. 1940 Feb 29;71(3):373-89 PMID: 19870969
INFECTIOUS MYXOMATOSIS OF RABBITS : II. DEMONSTRATION OF A SECOND SOLUBLE ANTIGEN ASSOCIATED WITH THE DISEASE.
J Exp Med. 1940 Jul 31;72(2):129-38 PMID: 19871012
THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY.
J Exp Med. 1942 Jan 31;75(2):165-78 PMID: 19871174

Article Info

Journal

The Journal of experimental medicine

Abbr.

J Exp Med

ISSN

0022-1007

DOI

10.1084/jem.75.2.151

Published

1942-01-31

Pages

151-64

Language

English

Region

United States

NLM ID

2985109R

PMCID

PMC2135236

External Links

PubMed source DOI: 10.1084/jem.75.2.151 PMC Full Text View journal details

Analysis Services

THE LS-ANTIGEN OF VACCINIA : I. INHIBITION OF L- AND S-ANTIBODIES BY SUBSTANCES IN TREATED VACCINE DERMAL FILTRATE.

Contact

WeChat Official Account